CAS NO: | 1354825-62-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | WEHI-345 analog is the analog of WEHI-345. WEHI-345 is a potent and selectiveRIPK2kinase inhibitor with an IC50of 0.13 μM, which delaysRIPK2ubiquitylation andNF-κBactivation on oligomerization domain (NOD) stimulation[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
分子量 | 415.49 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C23H25N7O | ||||||||||||||||
CAS 号 | 1354825-62-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 30 mg/mL(72.20 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |